Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Apr 24;5(5):390–397. doi: 10.7150/jca.7706

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.

PMC Copyright notice

The ISR monitoring of patients who experienced ISR during or after the observation period. After the observation period, we monitored the occurrence of ISR in patients who experienced ISR during the observation period. Patients who experienced ISR from fosaprepitant injection did not develop ISR again when they received subsequent chemotherapy with peroral administration of aprepitant. Gray panels indicate patients who experienced ISR; and white, patient had no ISRs. fAPR, fosaprepitant; APR, aprepitant; PV, peripheral vein; CV, central venous; and ISR, injection site reaction.